Crossmark

TH-302 (evofosfamide) monotherapy exerts anticancer activity in Ewing's sarcoma cells under hypoxia

Published Online: 2025-06-14

Authors

Kühne, Marie

Becker, Sabine

Sonnemann, Jürgen

Marx, Christian https://orcid.org/0000-0003-2240-8261
License Information

Text and Data Mining valid from 2025-06-14

Version of Record valid from 2025-06-14
More Information

Article History

Received: 16 February 2025

Accepted: 14 May 2025

First Online: 14 June 2025

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current